GLOBULIN SERUM, ANTI-HUMAN

Solicitation SPE2DS-26-T-460N is a request for quotes issued by the DLA Troop Support Medical Supply Chain for the procurement of six vials of Anti-Human Globulin Serum (NSN 6550-01-242-2234). This FDA-regulated product is used to detect human IgG bound to red blood cells and must be stored under refrigeration between 2 and 8 degrees Celsius. The item is subject to a non-extendable shelf life of 12 months, with a requirement that no more than one month elapses between the date of manufacture and the date of delivery to the government. Delivery is set for September 23, 2026, with the place of performance and delivery located in San Antonio, Texas. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires that all labels include the contract or lot number and the manufacture, expiration, or retest dates. Packaging must be commercial and utilize sealed unit containers to prevent damage, with hazardous materials labeled according to 29 CFR 1910.1200. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American Act and the Berry Amendment. Quotes must be submitted via the DLA Internet Bid Board System by September 28, 2026.